ABCB1 and acute myeloid leukemia: The influence of ABCB1 polymorphisms in anthracycline-related toxicities remains more controversial in AML, with scarce relevant findings [60,62] and without evidence of higher cardiotoxicity unlike studies in other malignancies [22,23,75,76].